+1-510-404-8135
The global biomaterials market was valued at $72.36 billion in 2016 and is expected to reach $151.65 billion by 2021, growing at a CAGR of 16.0% between 2017 and 2021.
The global biomaterials market in terms of value is estimated to witness growth at a CAGR of 16.0% between 2017 and 2021. The increasing demand and the growth rate for biomaterials in the market is attributed to their growing usage in applications of cardiovascular orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), and tissue engineering, among others, in the biomedical end-use industry.
The rising demand is in line with the unique properties and the biocompatabilty of biomaterials. The properties such as high strength, stiffness, corrosion resistance, fatigue strength, biofunctionality, and bioactivity make the biomaterials a preferred choice in the aforementioned applications.
The report is a compilation of various segmentations including market breakdown by biomaterial type, sub-type, end-use applications, and different geographical regions. It also includes sections on competitive insights and market dynamics. Herein, the revenue generated from the biomaterials market is tracked to calculate the market size.
While highlighting the key driving and restraining forces for this market, the report also provides a comprehensive section of the application areas of the biomaterials market. It also examines the role of the leading market players involved in this market.
The report addresses the following key questions about the global biomaterials market:
• What is the global biomaterials market size in terms of revenue from 2016-2021?
• Which is the dominant type by revenue in the biomaterials market?
• What is the revenue generated by the different biomaterials by type in the biomaterials market?
• What is the revenue generated by the different applications of the biomaterials market?
• What are the different factors driving the market in the forecast period?
• What are the major factors challenging the growth of the global biomaterials market?
• What are the opportunities for the global biomaterials market?
• What are the key future trends for the global biomaterials market?
• What kind of new strategies are being adopted by the existing market players to make a mark in the industry?
• What is the revenue generated by the different geographic regions in the biomaterials market?
• Which region will lead the global biomaterials market by the end of the forecast period?
• Which are the existing key market players that have made a mark in the biomaterials market?
The report has put special emphasis on the market share of the type and applications of the biomaterials, globally. The industry analyses have also been undertaken in order to examine the impact of various factors and understand the overall attractiveness of the industry.
The most often used strategy for developing a better hold on to the market has been through agreements, collaborations, contracts, and partnerships, followed by new product launches. The company profile section includes highlights of significant information about the key companies involved, along with their financial summaries and key strategies & developmental activities of recent years.
Some of the key players in the biomaterials market are BASF, BBS, Berkley Advanced Biomaterial Inc., Bioretec Ltd., CAM Bioceramics, Carpenter Technology Corporation, Celanese Corp., Collagen Solutions, Corbion, Covestro, Royal DSM, Evonik Industries, Invibio, Straumann, and Zimmer Biomet. These companies provide a broad product portfolio for specific needs and industrial applications.
Metal based biomaterials dominated the global biomaterials market with a share of approximately 24% in 2016. The cardiovascular application dominated the biomaterials market on the basis of application with a market share of 34% in 2016. On the basis of geography, North America dominated the biomaterials market with a market share of 42%, followed by Europe and Asia Pacific. Additionally, APAC has the highest potential to grow in the forecast period due to the presence of emerging economies such as China and India.
| TABLE OF CONTENT | ||
| Executive Summary | ||
| 1 | Scope and Research Methodology | |
| 1.1 | Report Scope | |
| 1.2 | Global Biomaterials Market Research Methodology | |
| 1.2.1 | Assumptions and Limitations | |
| 1.2.2 | Primary Research | |
| 1.2.3 | Secondary Research | |
| 1.2.4 | Data Triangulation | |
| 1.2.5 | Data Analyzing and Market Estimation | |
| 2 | Market Dynamics | |
| 2.1 | Market Drivers | |
| 2.1.1 | Increasing Funds/ Aids by the Government For Research Purposes | |
| 2.1.2 | Increasing Plastic Surgery and Wound Healing Therapies | |
| 2.1.3 | Increasing Aging/Geriatric Population | |
| 2.1.4 | Rise in Prevalence of Cardiovascular Diseases | |
| 2.1.5 | Increasing Orthopaedic Disorders | |
| 2.1.6 | Growing Demand for Implantable Devices | |
| 2.1.7 | Increasing Awareness of Regenerative Medicine | |
| 2.2 | Market Restraints/Challenges | |
| 2.2.1 | Biocompatibility Issues and Safety and Stringent Regulations | |
| 2.2.2 | Limitations of Biomaterial-Based Products | |
| 2.3 | Market Opportunities | |
| 2.3.1 | Increasing Obesity | |
| 2.3.2 | Patient Awareness and Improved Lifestyle in Emerging Economies | |
| 2.3.3 | Introduction of Biomaterials in Cancer Research | |
| 2.4 | Key Trends in the Biomaterials Market | |
| 3 | Competitive Insights | |
| 3.1 | Competitive Analysis | |
| 3.1.1 | Biomaterials Market Competitive Analysis | |
| 3.2 | Opportunity Matrix Analysis | |
| 3.3 | Country Share Analysis | |
| 3.4 | Biomaterials in Research & Development | |
| 3.5 | R&D Analysis of Key Market Players | |
| 3.6 | Key Strategies and Developments | |
| 3.6.1 | Agreements, Collaborations, Contracts, Joint Venture, & Partnerships | |
| 3.6.2 | Business Expansions | |
| 3.6.3 | New Product Launches & Developments | |
| 3.6.4 | Mergers & Acquisitions | |
| 3.6.5 | Others | |
| 4 | Industry Analysis | |
| 4.1 | Supply Chain Analysis | |
| 4.2 | Porter’s Five Forces Analysis | |
| 4.2.1 | Threat of New Entrants | |
| 4.2.2 | Threat of Substitutes | |
| 4.2.3 | Bargaining Power of Buyers | |
| 4.2.4 | Bargaining Power of Suppliers | |
| 4.2.5 | Intensity of Competitive Rivalry | |
| 4.3 | Future Trends and Developments in Biomaterials Market | |
| 5 | Global Biomaterials Market, by Type | |
| 5.1 | Metals | |
| 5.1.1 | Stainless Steel | |
| 5.1.2 | Titanium and Titanium alloys | |
| 5.1.3 | Co-Cr Alloys | |
| 5.1.4 | Magnesium | |
| 5.1.5 | Gold | |
| 5.1.6 | Silver | |
| 5.1.7 | Nitinol | |
| 5.1.8 | Other Metal Based Biomaterials | |
| 5.2 | Polymer Based Biomaterials | |
| 5.2.1 | Polyethylene Terephthalate (PET) | |
| 5.2.2 | Polypropylene (PP) | |
| 5.2.3 | Polyetheretherketone (PEEK) | |
| 5.2.4 | Ultra-High Molecular Weight Polyethylene (UHMWPE) | |
| 5.2.5 | Polytetrafluoroethylene (PTFE) | |
| 5.2.6 | Polyglycolide (PGA) | |
| 5.2.7 | Polyactide (PLA) | |
| 5.2.8 | Polycaprolactone (PCL) | |
| 5.2.9 | Polyglycerol Sebacate (PGS) | |
| 5.2.10 | Polyvinylchloride (PVC) | |
| 5.2.11 | Silicone Rubber | |
| 5.2.12 | Nylon | |
| 5.2.13 | Polymethyl Methacrylate (PMMA) | |
| 5.2.14 | Other Polymers | |
| 5.3 | Ceramic Based Biomaterials | |
| 5.3.1 | Alumina | |
| 5.3.2 | Calcium Phosphate | |
| 5.3.3 | Zirconia | |
| 5.3.4 | Calcium Sulphate | |
| 5.3.5 | Carbon | |
| 5.3.6 | Other Ceramic Based Biomaterials | |
| 5.4 | Natural Based Biomaterials | |
| 5.4.1 | Collagen | |
| 5.4.2 | Fibrin | |
| 5.4.3 | Gelatin | |
| 5.4.4 | Silk | |
| 5.4.5 | Alginates | |
| 5.4.6 | Hyaluronic Acid | |
| 5.4.7 | Chitin | |
| 5.4.8 | Cellulose | |
| 5.5 | Inorganic Glass Based Biomaterials | |
| 5.5.1 | Silicates | |
| 5.5.2 | Bioactive Glass | |
| 5.5.3 | Phosphate | |
| 5.6 | Radiopaque Biomaterials | |
| 5.7 | Regenerative Biomaterials | |
| 5.8 | Hybrid Biomaterial Combinations | |
| 6 | Global Biomaterials Market, by Application | |
| 6.1 | Cardiovascular | |
| 6.1.1 | Catheters | |
| 6.1.2 | Stents | |
| 6.1.3 | Heart Valves | |
| 6.1.4 | Guidewires | |
| 6.1.5 | Sensors | |
| 6.1.6 | Pacemaker | |
| 6.1.7 | Implantable Cardiac Defibrillators | |
| 6.1.8 | Vascular Grafts | |
| 6.2 | Orthopaedic | |
| 6.2.1 | Joint Replacement | |
| 6.2.1.1 | Hip Replacements | |
| 6.2.1.2 | Knee Replacements | |
| 6.2.1.3 | Shoulder Replacements | |
| 6.2.1.4 | Other Replacements | |
| 6.2.2 | Viscossupplementation | |
| 6.2.3 | Bioresorbable Tissue Fixation | |
| 6.2.3.1 | Suture Anchors | |
| 6.2.3.2 | Interference Screws | |
| 6.2.3.3 | Meshes | |
| 6.2.4 | Spine | |
| 6.2.4.1 | Minimally Invasive Fusion Surgeries | |
| 6.2.4.2 | Motion Preservation and Dynamic Stabilization | |
| 6.2.4.2.1 | Pedicle Based Rod Systems | |
| 6.2.4.2.2 | Interspinous Spacers | |
| 6.2.4.2.3 | Disc Arthoplasty/Replacement | |
| 6.2.5 | Fracture Fixation | |
| 6.2.5.1 | Bone Plates | |
| 6.2.5.2 | Screws | |
| 6.2.5.3 | Pins | |
| 6.2.5.4 | Rods | |
| 6.2.6 | Orthobiology | |
| 6.2.6.1 | Bone Grafts | |
| 6.3 | Ophthalmology | |
| 6.3.1 | Contact Lenses | |
| 6.3.2 | Intraocular Lenses | |
| 6.3.3 | Functional Replacement of Ocular Tissues | |
| 6.3.4 | Synthetic Corneas | |
| 6.3.5 | Others | |
| 6.4 | Dental | |
| 6.4.1 | Dental Bone Grafts and Substitutes | |
| 6.4.2 | Dental Membranes | |
| 6.5 | Wound Healing | |
| 6.5.1 | Wound Closure Devices | |
| 6.5.2 | Sutures | |
| 6.5.3 | Staples | |
| 6.5.4 | Surgical Haemostats | |
| 6.5.5 | Internatal Tissue Sealants | |
| 6.5.6 | Adhesion Barriers | |
| 6.5.7 | Hernia Meshes | |
| 6.6 | Plastic Surgery | |
| 6.6.1 | Soft-Tissue Fillers | |
| 6.6.2 | Craniofacial Surgery | |
| 6.7 | Neurological/Central Nervous System | |
| 6.7.1 | Shunting Systems | |
| 6.7.2 | Cortical Neural Prosthetics (CNP) | |
| 6.7.3 | Hydrogel Scaffolds for CNS Report | |
| 6.7.4 | Neural Stem Cell Encapsulation | |
| 6.8 | Tissue Engineering | |
| 6.8.1 | Scaffolds for Regenerative Medicine | |
| 6.8.2 | Nanomaterial for Biosensing | |
| 6.8.3 | Tailoring of Inorganic Nanoparticles | |
| 6.9 | Others | |
| 6.9.1 | Drug Delivery Systems | |
| 6.9.2 | Gastrointestinal Applications | |
| 6.9.3 | Bariatric Surgery | |
| 6.9.4 | Urinary Applications | |
| 7 | Global Biomaterials Market, by Region | |
| 7.1 | North America | |
| 7.1.1 | Biomaterials Market, by Type | |
| 7.1.2 | Biomaterials Market, by Application | |
| 7.1.3 | Biomaterials Market, by Country | |
| 7.1.3.1 | The U.S. | |
| 7.1.3.1.1 | Biomaterials-Based Research in the U.S | |
| 7.1.3.1.2 | Growing Demand for Plastic Surgeries in the U.S. | |
| 7.1.3.1.3 | Conferences and Symposiums on Biomaterials in the U.S. | |
| 7.1.3.1.4 | Increase in Cancer Incidence | |
| 7.1.3.1.5 | Growing Prevalence of Cardiovascular Diseases | |
| 7.1.3.1.6 | Regulations in the U.S. | |
| 7.1.3.2 | Canada | |
| 7.1.3.2.1 | Growth in the Aging Population | |
| 7.1.3.2.2 | Growing Development Activities for Biomaterials in Canada | |
| 7.1.3.3 | Mexico | |
| 7.1.3.3.1 | Growing R&D activity for Biomaterials in Mexico | |
| 7.1.3.3.2 | Emergence of Dental Growth | |
| 7.2 | Europe | |
| 7.2.1 | Biomaterials Market, by Type | |
| 7.2.2 | Biomaterials Market, by Application | |
| 7.2.3 | Biomaterials Market, by Country | |
| 7.2.3.1 | Germany | |
| 7.2.3.2 | The U.K. | |
| 7.2.3.3 | France | |
| 7.2.3.4 | Spain | |
| 7.2.3.5 | Italy | |
| 7.2.3.6 | Russia | |
| 7.2.3.7 | Rest of Europe(RoE) | |
| 7.3 | Asia Pacific | |
| 7.3.1 | Biomaterials Market, by Type | |
| 7.3.2 | Biomaterials Market, by Application | |
| 7.3.3 | Biomaterials Market, by Country | |
| 7.3.3.1 | China | |
| 7.3.3.2 | Japan | |
| 7.3.3.3 | India | |
| 7.3.3.4 | South Korea | |
| 7.3.3.5 | Rest of Asia Pacific | |
| 7.4 | Middle East & Africa | |
| 7.4.1 | Biomaterials Market, by Type | |
| 7.5 | South America | |
| 7.5.1 | Biomaterials Market, by Type | |
| 8 | Company Profiles | |
| 8.1 | BASF SE | |
| 8.1.1 | Company Overview | |
| 8.1.2 | Financials | |
| 8.1.2.1 | Financial Summary | |
| 8.1.3 | BASF SE: SWOT Analysis | |
| 8.2 | Bioactive Bone Substitutes Ltd. | |
| 8.2.1 | Company Overview | |
| 8.2.2 | About the Company | |
| 8.3 | Berkeley Advanced Biomaterials Inc. | |
| 8.3.1 | Company Overview | |
| 8.3.2 | Product Portfolio | |
| 8.3.3 | About the Company | |
| 8.4 | Bioretec Ltd. | |
| 8.4.1 | Company Overview | |
| 8.4.2 | About the Company | |
| 8.5 | CAM Bioceramics B.V. | |
| 8.5.1 | Company Overview | |
| 8.5.2 | About the Company | |
| 8.6 | Carpenter Technology Corporation | |
| 8.6.1 | Company Overview | |
| 8.6.2 | Product Portfolio | |
| 8.6.3 | Overall Financials | |
| 8.6.3.1 | Financial Summary | |
| 8.6.4 | SWOT Analysis | |
| 8.7 | Celanese Corporation | |
| 8.7.1 | Company Overview | |
| 8.7.2 | Product Portfolio | |
| 8.7.3 | Financials | |
| 8.7.3.1 | Financial Summary | |
| 8.7.4 | SWOT Analysis | |
| 8.8 | Collagen Solutions | |
| 8.8.1 | Company Overview | |
| 8.8.2 | Product Portfolio | |
| 8.8.3 | Overall Financials | |
| 8.8.3.1 | Financial Summary | |
| 8.8.4 | SWOT Analysis | |
| 8.9 | Corbion N.V. | |
| 8.9.1 | Company Overview | |
| 8.9.2 | Overall Financials: | |
| 8.9.2.1 | Financial Summary | |
| 8.9.3 | SWOT Analysis | |
| 8.1 | Covestro AG | |
| 8.10.1 | Company Overview | |
| 8.10.2 | Product Portfolio | |
| 8.10.3 | Overall Financials: | |
| 8.10.3.1 | Financial Summary | |
| 8.10.4 | SWOT Analysis | |
| 8.11 | Koninklijke DSM N.V. | |
| 8.11.1 | Company Overview | |
| 8.11.2 | Product Portfolio | |
| 8.11.3 | Overall Financials: | |
| 8.11.3.1 | Financial Summary | |
| 8.11.4 | SWOT Analysis | |
| 8.12 | Evonik Industries | |
| 8.12.1 | Company Overview | |
| 8.12.2 | Product Portfolio | |
| 8.12.3 | Overall Financials: | |
| 8.12.3.1 | Financial Summary | |
| 8.12.4 | SWOT Analysis | |
| 8.13 | Invibio Biomaterial Solutions | |
| 8.13.1 | Company Overview | |
| 8.13.2 | About the Company | |
| 8.14 | Regentis Biomaterials | |
| 8.14.1 | Company Overview | |
| 8.14.2 | About the Company | |
| 8.15 | Zimmer Biomet Holdings Inc. | |
| 8.15.1 | Company Overview | |
| 8.15.2 | Product Portfolio | |
| 8.15.3 | Overall Financials: | |
| 8.15.3.1 | Financial Summary | |
| 8.15.4 | SWOT Analysis | |
| List of Tables | ||
| Table 1 | Global Biomaterials Market Snapshot, 2017 and 2021 | |
| Table 3.1 | Biomaterials Market Competitive Analysis, by Revenue, 2016 | |
| Table 3.2 | Agreements, Contracts, Collaborations, Joint Ventures & Partnerships | |
| Table 3.3 | Key Business Expansion Activities | |
| Table 3.4 | Key Product Launches | |
| Table 3.5 | Key Mergers & Acquisitions | |
| Table 3.6 | Other Developments | |
| Table 5.1 | Global Biomaterials Market, by Type, (2016 – 2021) | |
| Table 5.2 | Metal based Biomaterials used in the Biomedical Application | |
| Table 5.3 | Global Metal Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.4 | Synthetic and Natural Polymers Used in Biomedical Applications | |
| Table 5.5 | PEEK Based biomaterials | |
| Table 5.6 | Global Metal Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.7 | Properties of Polymers Needed for Specific Biomaterials Applications | |
| Table 5.8 | Overview of Ceramic based Biomaterials Market | |
| Table 5.9 | Global Ceramic Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.10 | Different Types of Ceramic Needed for Biomaterial Applications | |
| Table 5.11 | Collagen Biomaterials Market, by Region, 2016-2021 | |
| Table 5.12 | Global Inorganic Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.13 | Global Radiopaque Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.14 | Global Regenerative Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.15 | Global Hybrid Biomaterials Combinations Market, by Region, (2016 – 2021) | |
| Table 6.1 | Application Overview of Biomaterials, by Devices | |
| Table 6.2 | Global Biomaterials Market, by Application, (2016 – 2021) | |
| Table 6.3 | Biomaterials used in Cardiovascular system | |
| Table 6.4 | Cardiovascular Biomaterials Market, by Medical Devices, (2016 – 2021) | |
| Table 6.5 | Cardiovascular Biomaterials Market, by Region, (2016 – 2021) | |
| Table 6.6 | Factors Leading to the Cardiovascular Diseases in North America | |
| Table 6.7 | Biomaterials used in Orthopedic Applications | |
| Table 6.8 | Orthopedic Biomaterials Market, by Sub-Application, (2016 – 2021) | |
| Table 6.9 | Past vs. Present Materials used in Hip, Shoulder, and Knee Replacements | |
| Table 6.10 | Joint Replacement Orthopedic Biomaterials Materials Market, by Type, (2016 – 2021) | |
| Table 6.11 | FDA Approved Injectable HA Viscossupplementation Products | |
| Table 6.12 | Degradation Time of Biomaterials Used in Bioabsorbable Suture Anchors | |
| Table 6.13 | Degradation Time of Biomaterials used in Biresorbable Suture Anchors | |
| Table 6.14 | Orthopedic Biomaterials Market, by Region, (2016 – 2021) | |
| Table 6.15 | Ophthalmology Biomaterials Market, by Region, (2016 – 2021) | |
| Table 6.16 | Dental Biomaterials Market, by Region, (2016-2021) | |
| Table 6.17 | Wound Healing Biomaterials Market, by Region (2016-2021) | |
| Table 6.18 | Surgical Procedures Performed for Plastic Surgery, By Country, 2015 | |
| Table 6.19 | Non-Surgical Procedures Performed for Plastic Surgery, By Country, 2015 | |
| Table 6.20 | Plastic Surgery Biomaterials Market, by Region (2016-2021) | |
| Table 6.21 | Neurological/Central Nervous System Biomaterials Market, by Region (2016-2021) | |
| Table 6.22 | Tissue Engineering Biomaterials Market, by Region (2016-2021) | |
| Table 6.23 | Other Applications Biomaterials Market, by Region (2016-2021) | |
| Table 7.1 | Global Biomaterials Market, by Region, (2016 – 2021) | |
| Table 7.2 | North American Biomaterials Market, by Type, (2016 – 2021) | |
| Table 7.3 | North America Biomaterials Market, by Application, (2016 – 2021) | |
| Table 7.4 | North American Biomaterials Market by Country, (2016 – 2021) | |
| Table 7.5 | The U.S. Biomaterials Market, by Application, (2016–2021) | |
| Table 7.6 | Canadian Population on Basis of Age above 65, 1851 to 2041 | |
| Table 7.7 | Canadian Biomaterials Market, by Application, 2017-2021 | |
| Table 7.8 | Mexico Biomaterials Market, by Application, 2017-2021 | |
| Table 7.9 | European Biomaterials Market (2016-2021), by Type | |
| Table 7.10 | European Biomaterials Market, by Application, (2016-2021) | |
| Table 7.11 | European Biomaterials Market by Country, (2016 – 2021) | |
| Table 7.12 | German Biomaterials Market, by Application, (2016–2021) | |
| Table 7.13 | The U.K. Biomaterials Market, by Application, (2016–2021) | |
| Table 7.14 | France Biomaterials Market, by Application, (2016–2021) | |
| Table 7.15 | Spain Biomaterials Market, by Application, (2016–2021) | |
| Table 7.16 | Italy Biomaterials Market, by Application, (2016–2021) | |
| Table 7.17 | Russian Biomaterials Market, by Application, (2016–2021) | |
| Table 7.18 | Rest of Europe Biomaterials Market, by Application, (2016–2021) | |
| Table 7.19 | Asia-Pacific Biomaterials Market, by Type, (2016-2021) | |
| Table 7.20 | Asia-Pacific Biomaterials Market, by Application, (2016 – 2021) | |
| Table 7.21 | Asia-Pacific Biomaterials Market by Country, (2016 – 2021) | |
| Table 7.22 | China Biomaterials Market, by Application, (2016–2021) | |
| Table 7.23 | Japan Biomaterials Market, by Application, (2016–2021) | |
| Table 7.24 | India Biomaterials Market, by Application, (2016–2021) | |
| Table 7.25 | South Korean Biomaterials Market, by Application, 2016-2021 | |
| Table 7.26 | Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021 | |
| Table 7.27 | Middle East & Africa Biomaterials Market, by Type, (2016 – 2021) | |
| Table 7.28 | Middle East & Africa Biomaterials Market, by Application, (2016 – 2021) | |
| Table 7.29 | South American Biomaterials Market, by Type, (2016 – 2021) | |
| Table 7.30 | South American Biomaterials Market, by Application, (2016 – 2021) | |
| List of Figures | ||
| Figure 1 | Evolution of Biomaterials | |
| Figure 2 | Global Biomaterials Market Snapshot, 2016-2021 | |
| Figure 3 | Global Biomaterials Market Share and Size, by Type, 2017 and 2021 | |
| Figure 4 | Global Biomaterials Market Share, by Application: 2017 & 2021 | |
| Figure 5 | Global Biomaterials Market, by Region, 2017 and 2021 | |
| Figure 6 | Global Biomaterials Market, by Country, 2016 and 2021 | |
| Figure 1.1 | Global Biomaterials Market Scope | |
| Figure 1.2 | Report Design | |
| Figure 1.3 | Sources of Secondary Research | |
| Figure 1.4 | Data Triangulation | |
| Figure 1.5 | Top Down & Bottom Up Approach | |
| Figure 2.1 | Global Biomaterials Market Dynamics | |
| Figure 2.2 | Number of Plastic Surgery Procedures and Percentage Share, by Country, 2014 | |
| Figure 2.3 | Number of Plastic Surgery Procedures in the U.S., by Type, 2015 | |
| Figure 2.4 | Global Percentage of Aging Population | |
| Figure 2.5 | Global Percentage of Aging Population | |
| Figure 2.6 | Cardiovascular Disease Death Rates, By Country, 2014 | |
| Figure 2.7 | Key Facts about Joint Replacement (2014-2015) | |
| Figure 2.8 | Global Medical Implants, by Application | |
| Figure 2.9 | Medical Implants in the Human Body | |
| Figure 2.10 | Key Trends in the Biomaterials Market | |
| Figure 3.1 | Global Biomaterials Market Opportunity Matrix, by Region, 2016 | |
| Figure 3.2 | Global Biomaterials Market Opportunity Matrix, by Country, 2016 | |
| Figure 3.3 | Global Biomaterials Market Opportunity Matrix, by Country, 2021 | |
| Figure 3.4 | Country Share Analysis of Global Biomaterials Market, 2016 | |
| Figure 3.5 | R&D Focus Areas of Axio Bio | |
| Figure 3.6 | R&D Analysis of Key Market Players | |
| Figure 3.7 | Share of Key Market Strategies & Developments | |
| Figure 3.8 | Total Number of Strategies & Developments | |
| Figure 4.1 | Supply Chain Analysis of Biomaterials Market | |
| Figure 4.2 | Biomaterial Science and a Path from a Need to Manufactured Medical Device | |
| Figure 4.3 | Porter’s Five Forces Analysis of Biomaterials Market | |
| Figure 4.4 | Future Trends and Developments in the Biomaterials Market | |
| Figure 5.1 | Global Biomaterials Market Size, by Type, 2017 and 2021 | |
| Figure 5.2 | Global Biomaterials Market, by Type, 2016-2021 | |
| Figure 5.3 | Global Biomaterials Market Share, by Type, 2016-2021 | |
| Figure 5.4 | Different Types of Biomaterials in Different Applications | |
| Figure 5.5 | Global Metal based Biomaterials Market Size, (2016 – 2021) | |
| Figure 5.6 | Evolution of Gold based Biomaterials in Medical Applications | |
| Figure 5.7 | Application Overview of Gold | |
| Figure 5.8 | Application Overview of Nitinol Based Biomaterials | |
| Figure 5.9 | Alloy Composition of Nitinol | |
| Figure 5.10 | Global Metal Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.11 | Global Polymer Based Biomaterials Market, 2017-2021 | |
| Figure 5.12 | Polymer based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.13 | Global Ceramic Based Biomaterials Market, 2017-2021 | |
| Figure 5.14 | Ceramic Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.15 | Global Natural Biomaterials Market, 2017-2021 | |
| Figure 5.16 | Collagen Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.17 | Properties of Inorganic Glass | |
| Figure 5.18 | Inorganic Glass Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.19 | History of Calcium Phosphate Based Biomaterials | |
| Figure 5.20 | Inorganic Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.21 | Global Radiopaque Biomaterials Market, 2017-2021 | |
| Figure 5.22 | Radiopaque Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.23 | Regenerative Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.24 | Global Hybrid Biomaterial Combinations Market, 2017-2021 | |
| Figure 5.25 | Hybrid Biomaterial Combinations Market, by Region, 2016-2021 | |
| Figure 6.1 | Global Biomaterials Market, by Application | |
| Figure 6.2 | Global Biomaterials Market, by Application, 2017 and 2021 | |
| Figure 6.3 | Medical Devices and their Blood Contact Time | |
| Figure 6.4 | Number of Procedures in Joint Construction, 2016 | |
| Figure 6.5 | Global Ophthalmology Biomaterials Market, 2017-2021 | |
| Figure 6.6 | Properties of Polymer Based Biomaterials in Ophthalmology | |
| Figure 6.7 | Percent Share of Contact Lenses, by Region, 2014 | |
| Figure 6.8 | Global Dental Biomaterials Market, (2016-2021) | |
| Figure 6.9 | Key Facts and Figures on Dental Implantation in America | |
| Figure 6.10 | Global Wound Healing Biomaterials Market, (2016 – 2021) | |
| Figure 6.11 | Global Plastic Surgery Biomaterials Market, (2016 – 2021) | |
| Figure 6.12 | Global Neurological/Central Nervous System Biomaterials Market, (2016 – 2021) | |
| Figure 6.13 | Formation Engineered Tissue | |
| Figure 6.14 | Global Tissue Engineering Biomaterials Market, (2016 – 2021) | |
| Figure 6.15 | Properties of Biomaterial Scaffolds | |
| Figure 6.16 | Global Other Applications Biomaterials Market, (2016 – 2021) | |
| Figure 7.1 | Biomaterials Market Growth Rate, by Region | |
| Figure 7.2 | Biomaterials Market Growth Rate, by Region, 2017 and 2021 | |
| Figure 7.3 | North American Biomaterials Market Snapshot, 2016-2021 | |
| Figure 7.4 | Factors Driving the Biomaterials Market in North American Biomaterials, 2017 and 2021 | |
| Figure 7.5 | North American Distribution of Orthopedic Surgery Procedures, 2015 | |
| Figure 7.6 | Surgical Procedures in North America, 2015 and 2016 | |
| Figure 7.7 | Non-Surgical Procedures in North America, 2015 and 2016 | |
| Figure 7.8 | The U.S. Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.9 | Increase in Plastic Surgeries in the U.S. from 2000 to 2015 | |
| Figure 7.10 | Cancer Cases and Death Estimation in the U.S., 2017 | |
| Figure 7.11 | Facts and Risks Associated with Cardiovascular Diseases in the U.S. | |
| Figure 7.12 | Canadian Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.13 | Facts and Risks associated with Cardiovascular Diseases in the Canada | |
| Figure 7.14 | Mexico Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.15 | Global European Biomaterials Market, 2017-2021 | |
| Figure 7.16 | Factors Driving the Biomaterials Market in European Biomaterials, 2017 and 2021 | |
| Figure 7.17 | Percent Share of different Kind of Diseases in Europe, by Male and Female, 2016 | |
| Figure 7.18 | German Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.19 | The U.K. Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.20 | Common Plastic Surgery Procedure in the U.K. | |
| Figure 7.21 | France Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.22 | Spain Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.23 | Italy Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.24 | Russia Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.25 | Rest of Europe Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.26 | Asia-Pacific Biomaterials Market Snapshot, 2016-2021 | |
| Figure 7.27 | Factors Driving the Biomaterials Market in Asia-Pacific, 2017 and 2021 | |
| Figure 7.28 | China Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.29 | Japan Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.30 | India Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.31 | Percentage of Heart Attack among Indians for Different Age Groups | |
| Figure 7.32 | South Korean Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.33 | Indonesian Medical Device Regulation System | |
| Figure 7.34 | Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.35 | Middle East & Africa Biomaterials Market, 2017-2021 | |
| Figure 7.36 | South American Biomaterials Market, by Type, 2017-2021 | |
| Figure 8.1 | BASF SE: Overall Financials, 2014-2016 | |
| Figure 8.2 | BASF SE: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.3 | BASF SE: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.4 | Carpenter Technology Corporation: Overall Financials, 2014-2016 | |
| Figure 8.5 | Carpenter Technology Corporation: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.6 | Carpenter Technology Corporation: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.7 | Celanese Corporation: Overall Financials, 2014-2016 | |
| Figure 8.8 | Celanese Corporation: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.9 | Celanese Corporation: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.10 | Collagen Solutions: Overall Financials, 2014-2016 | |
| Figure 8.11 | Collagen Solutions: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.12 | Corbion N.V.: Overall Financials, 2014-2016 | |
| Figure 8.13 | Corbion N.V.: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.14 | Corbion N.V.: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.15 | Corbion N.V.: Biochemical Sub-Segment Revenue Mix, 2014-2016 | |
| Figure 8.16 | Covestro AG: Overall Financials, 2014-2016 | |
| Figure 8.17 | Covestro AG: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.18 | Covestro AG: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.19 | Koninklijke DSM N.V.: Overall Financials, 2014-2016 | |
| Figure 8.20 | Koninklijke DSM N.V.: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.21 | Koninklijke DSM N.V.: Business Segment Revenue Mix, 2013-2015 | |
| Figure 8.22 | Evonik Industries: Overall Financials, 2014-2016 | |
| Figure 8.23 | Evonik Industries: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.24 | Evonik Industries: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.25 | Zimmer Biomet Holdings Inc.: Overall Financials, 2014-2016 | |
| Figure 8.26 | Zimmer Biomet Holdings Inc.: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.27 | Zimmer Biomet Holdings Inc.: Business Segment Revenue Mix, 2014-2016 | |
Biomaterial is referred to any substance which is engineered to become biocompatible for its interaction with the biological systems. Biomaterials can be categorized as synthetic and natural. The synthetic materials consist of metals, polymers and ceramics, whereas natural biomaterials derived from natural sources include animal tissues or are engineered in the laboratory. Some tissues are harvested from animal sources such as cows or pigs. The interaction of these biomaterials with the human body aids in the treatment, augmentation, repairing or replacement of a tissue in the body.
The biomaterials market is majorly segmented by type, application and geography. The major categories by type include metal based, polymer based, ceramic based, regenerative biomaterials, inorganic glass, radiopaque biomaterials, natural biomaterials and hybrid combinations biomaterials. The major applications include cardiovascular, orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), tissue engineering and others such as drug delivery, urinary applications among others. By geography, the global biomaterials is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa and Latin America. The global biomaterials market is expected to reach $151.65 billion by 2021, growing at a CAGR of 16.0% between 2017 and 2021.
The biomaterials market is driven by a number of factors such as superior properties of biomaterials, increasing funds as well as aids by government for research purposes, rise in wound healing therapies & plastic surgeries, growing geriatric population, rising prevalence of cardiovascular diseases, increasing awareness of regenerative medicine, high rate of orthopedic disorders, and growing demand for implantable devices. However, biocompatabilty issues, stringent safety regulations, and limitations of biomaterial based products are hampering the growth of the biomaterials market. Increasing obesity, introduction of biomaterials in cancer research, and rising patient awareness and improved lifestyle in growing economies such as India, China, and Brazil are expected to create opportunities in the biomaterials market.
Figure 1
Global Biomaterials Market Snapshot
Secondary research, Annual Reports, SEC Filings, Investor Presentations, Articles, Expert Insights, and BIS Research Analysis
The biomaterials market is segmented into various types, namely: metal based (such as stainless steel, cobalt-chrome alloys, titanium and titanium alloys, gold, silver, magnesium, and nitinol), polymer based (such as polypropylene, polyethylene terephthalate, polyetheretherketone, polytetrafluoroethylene, polyglycolide, silicone rubber, and PMMA, among others), ceramic based (such as calcium phosphate, zirconia, calcium sulphate, and carbon, among others), regenerative biomaterials, inorganic glass, radiopaque biomaterials, natural biomaterials (such as hyaluronic acid, collagen, gelatin, fibrin, cellulose, chitin, and silk, among others), and hybrid combinations biomaterials. Metal based biomaterials dominated the global biomaterials market with a share of approximately 24% in 2016. The market size of this segment is projected to reach $34.62 billion by 2021. Exceptionally high strength, biocompatibility and biodegradable properties allow these metals to be viably used for biomaterial applications.
The metallic biomaterials and their alloys are used majorly in load-bearing applications for which the desired properties are high strength, stiffness, corrosion resistance, fatigue strength, easy sterilization, shape memory and biocompatabilty, among others. For similar reasons, metals are the most widely used biomaterials for load-bearing implants and orthopedic surgeries involving metallic implants. Metals are used in all the applications of biomaterials such as cardiovascular, orthopedic, ophthalmology, and dental, among others. From simple wires, rods, pins, screws to fracture fixation plates and total joint prostheses (artificial joints) for hips, knees, shoulders, and ankles, among others, metals are used in all kinds of applications including maxillofacial surgery, cardiovascular surgery, dental materials etc.
On the basis of application, biomaterials market is segmented into cardiovascular, orthopedics, ophthalmology, wound healing, plastic surgery, tissue engineering, neurological/central nervous system, and others. The cardiovascular application segment dominated the biomaterials market with a market share of approximately 34% in 2016. The increasing use of biomaterials in cardiovascular applications is majorly subjected to its biocompatibility as biomaterials comes in contact blood, vascular endothelial cells, fibroblasts, and myocardium, as well as a number of other cells and a cellular matrix material.
Additionally, according to World Health Organization (WHO), in 2015, approximately 17.7 million population died from cardiovascular diseases, thereby, representing 31% of all the global deaths. The main risk factors of the cardiovascular diseases include tobacco use, diabetes, hyperlipidemia, unhealthy diet and obesity, physical inactivity, alcohol consumption, hypertension, and stroke, among others. Out of 17.7 million deaths, approximately 7.4 million people died due to coronary heart disease and 6.7 million from stroke.
On the basis of geography, North America dominated the biomaterials market. The increasing demand for surgeries such as cosmetic, and orthopedic (joint replacement) among others, in the healthcare industry is giving a much needed thrust to the biomaterials market in the North American region. Another major reason behind the growth of the biomaterials market in the North American region is that the countries such as the U.S., Canada, and Mexico have a strong support of the government in terms of grants, funds and subsidies in R&D activities. Some of the major players operating in the North American region include Royal DSM, Invibio Ltd., Carpenter Technology Corporation, CAM Bio ceramics BV, Collagen Solutions PLC, Berkeley Advanced Biomaterials, Corbion N.V., Zimmer Biomet Holdings, Inc., and Evonik Industries AG.
Some of the key players in the biomaterials market are BASF, BBS, Berkley Advanced Biomaterial Inc., Bioretec Ltd., CAM Bioceramics, Carpenter Technology Corporation, Celanese Corp., Collagen Solutions, Corbion, Covestro, Royal DSM, Evonik Industries, Invibio, Straumann, and Zimmer Biomet. These companies provide a broad product portfolio for specific needs and industrial applications. These companies are actively aiming at an increased number of agreements, partnerships, collaborations, & contracts and products to expand their operations, thereby, enhancing their share in the biomaterials market.
We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.
With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.
Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.
The global biomaterials market in terms of value is estimated to witness growth at a CAGR of 16.0% between 2017 and 2021. The increasing demand and the growth rate for biomaterials in the market is attributed to their growing usage in applications of cardiovascular orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), and tissue engineering, among others, in the biomedical end-use industry.
The rising demand is in line with the unique properties and the biocompatabilty of biomaterials. The properties such as high strength, stiffness, corrosion resistance, fatigue strength, biofunctionality, and bioactivity make the biomaterials a preferred choice in the aforementioned applications.
The report is a compilation of various segmentations including market breakdown by biomaterial type, sub-type, end-use applications, and different geographical regions. It also includes sections on competitive insights and market dynamics. Herein, the revenue generated from the biomaterials market is tracked to calculate the market size.
While highlighting the key driving and restraining forces for this market, the report also provides a comprehensive section of the application areas of the biomaterials market. It also examines the role of the leading market players involved in this market.
The report addresses the following key questions about the global biomaterials market:
• What is the global biomaterials market size in terms of revenue from 2016-2021?
• Which is the dominant type by revenue in the biomaterials market?
• What is the revenue generated by the different biomaterials by type in the biomaterials market?
• What is the revenue generated by the different applications of the biomaterials market?
• What are the different factors driving the market in the forecast period?
• What are the major factors challenging the growth of the global biomaterials market?
• What are the opportunities for the global biomaterials market?
• What are the key future trends for the global biomaterials market?
• What kind of new strategies are being adopted by the existing market players to make a mark in the industry?
• What is the revenue generated by the different geographic regions in the biomaterials market?
• Which region will lead the global biomaterials market by the end of the forecast period?
• Which are the existing key market players that have made a mark in the biomaterials market?
The report has put special emphasis on the market share of the type and applications of the biomaterials, globally. The industry analyses have also been undertaken in order to examine the impact of various factors and understand the overall attractiveness of the industry.
The most often used strategy for developing a better hold on to the market has been through agreements, collaborations, contracts, and partnerships, followed by new product launches. The company profile section includes highlights of significant information about the key companies involved, along with their financial summaries and key strategies & developmental activities of recent years.
Some of the key players in the biomaterials market are BASF, BBS, Berkley Advanced Biomaterial Inc., Bioretec Ltd., CAM Bioceramics, Carpenter Technology Corporation, Celanese Corp., Collagen Solutions, Corbion, Covestro, Royal DSM, Evonik Industries, Invibio, Straumann, and Zimmer Biomet. These companies provide a broad product portfolio for specific needs and industrial applications.
Metal based biomaterials dominated the global biomaterials market with a share of approximately 24% in 2016. The cardiovascular application dominated the biomaterials market on the basis of application with a market share of 34% in 2016. On the basis of geography, North America dominated the biomaterials market with a market share of 42%, followed by Europe and Asia Pacific. Additionally, APAC has the highest potential to grow in the forecast period due to the presence of emerging economies such as China and India.
| TABLE OF CONTENT | ||
| Executive Summary | ||
| 1 | Scope and Research Methodology | |
| 1.1 | Report Scope | |
| 1.2 | Global Biomaterials Market Research Methodology | |
| 1.2.1 | Assumptions and Limitations | |
| 1.2.2 | Primary Research | |
| 1.2.3 | Secondary Research | |
| 1.2.4 | Data Triangulation | |
| 1.2.5 | Data Analyzing and Market Estimation | |
| 2 | Market Dynamics | |
| 2.1 | Market Drivers | |
| 2.1.1 | Increasing Funds/ Aids by the Government For Research Purposes | |
| 2.1.2 | Increasing Plastic Surgery and Wound Healing Therapies | |
| 2.1.3 | Increasing Aging/Geriatric Population | |
| 2.1.4 | Rise in Prevalence of Cardiovascular Diseases | |
| 2.1.5 | Increasing Orthopaedic Disorders | |
| 2.1.6 | Growing Demand for Implantable Devices | |
| 2.1.7 | Increasing Awareness of Regenerative Medicine | |
| 2.2 | Market Restraints/Challenges | |
| 2.2.1 | Biocompatibility Issues and Safety and Stringent Regulations | |
| 2.2.2 | Limitations of Biomaterial-Based Products | |
| 2.3 | Market Opportunities | |
| 2.3.1 | Increasing Obesity | |
| 2.3.2 | Patient Awareness and Improved Lifestyle in Emerging Economies | |
| 2.3.3 | Introduction of Biomaterials in Cancer Research | |
| 2.4 | Key Trends in the Biomaterials Market | |
| 3 | Competitive Insights | |
| 3.1 | Competitive Analysis | |
| 3.1.1 | Biomaterials Market Competitive Analysis | |
| 3.2 | Opportunity Matrix Analysis | |
| 3.3 | Country Share Analysis | |
| 3.4 | Biomaterials in Research & Development | |
| 3.5 | R&D Analysis of Key Market Players | |
| 3.6 | Key Strategies and Developments | |
| 3.6.1 | Agreements, Collaborations, Contracts, Joint Venture, & Partnerships | |
| 3.6.2 | Business Expansions | |
| 3.6.3 | New Product Launches & Developments | |
| 3.6.4 | Mergers & Acquisitions | |
| 3.6.5 | Others | |
| 4 | Industry Analysis | |
| 4.1 | Supply Chain Analysis | |
| 4.2 | Porter’s Five Forces Analysis | |
| 4.2.1 | Threat of New Entrants | |
| 4.2.2 | Threat of Substitutes | |
| 4.2.3 | Bargaining Power of Buyers | |
| 4.2.4 | Bargaining Power of Suppliers | |
| 4.2.5 | Intensity of Competitive Rivalry | |
| 4.3 | Future Trends and Developments in Biomaterials Market | |
| 5 | Global Biomaterials Market, by Type | |
| 5.1 | Metals | |
| 5.1.1 | Stainless Steel | |
| 5.1.2 | Titanium and Titanium alloys | |
| 5.1.3 | Co-Cr Alloys | |
| 5.1.4 | Magnesium | |
| 5.1.5 | Gold | |
| 5.1.6 | Silver | |
| 5.1.7 | Nitinol | |
| 5.1.8 | Other Metal Based Biomaterials | |
| 5.2 | Polymer Based Biomaterials | |
| 5.2.1 | Polyethylene Terephthalate (PET) | |
| 5.2.2 | Polypropylene (PP) | |
| 5.2.3 | Polyetheretherketone (PEEK) | |
| 5.2.4 | Ultra-High Molecular Weight Polyethylene (UHMWPE) | |
| 5.2.5 | Polytetrafluoroethylene (PTFE) | |
| 5.2.6 | Polyglycolide (PGA) | |
| 5.2.7 | Polyactide (PLA) | |
| 5.2.8 | Polycaprolactone (PCL) | |
| 5.2.9 | Polyglycerol Sebacate (PGS) | |
| 5.2.10 | Polyvinylchloride (PVC) | |
| 5.2.11 | Silicone Rubber | |
| 5.2.12 | Nylon | |
| 5.2.13 | Polymethyl Methacrylate (PMMA) | |
| 5.2.14 | Other Polymers | |
| 5.3 | Ceramic Based Biomaterials | |
| 5.3.1 | Alumina | |
| 5.3.2 | Calcium Phosphate | |
| 5.3.3 | Zirconia | |
| 5.3.4 | Calcium Sulphate | |
| 5.3.5 | Carbon | |
| 5.3.6 | Other Ceramic Based Biomaterials | |
| 5.4 | Natural Based Biomaterials | |
| 5.4.1 | Collagen | |
| 5.4.2 | Fibrin | |
| 5.4.3 | Gelatin | |
| 5.4.4 | Silk | |
| 5.4.5 | Alginates | |
| 5.4.6 | Hyaluronic Acid | |
| 5.4.7 | Chitin | |
| 5.4.8 | Cellulose | |
| 5.5 | Inorganic Glass Based Biomaterials | |
| 5.5.1 | Silicates | |
| 5.5.2 | Bioactive Glass | |
| 5.5.3 | Phosphate | |
| 5.6 | Radiopaque Biomaterials | |
| 5.7 | Regenerative Biomaterials | |
| 5.8 | Hybrid Biomaterial Combinations | |
| 6 | Global Biomaterials Market, by Application | |
| 6.1 | Cardiovascular | |
| 6.1.1 | Catheters | |
| 6.1.2 | Stents | |
| 6.1.3 | Heart Valves | |
| 6.1.4 | Guidewires | |
| 6.1.5 | Sensors | |
| 6.1.6 | Pacemaker | |
| 6.1.7 | Implantable Cardiac Defibrillators | |
| 6.1.8 | Vascular Grafts | |
| 6.2 | Orthopaedic | |
| 6.2.1 | Joint Replacement | |
| 6.2.1.1 | Hip Replacements | |
| 6.2.1.2 | Knee Replacements | |
| 6.2.1.3 | Shoulder Replacements | |
| 6.2.1.4 | Other Replacements | |
| 6.2.2 | Viscossupplementation | |
| 6.2.3 | Bioresorbable Tissue Fixation | |
| 6.2.3.1 | Suture Anchors | |
| 6.2.3.2 | Interference Screws | |
| 6.2.3.3 | Meshes | |
| 6.2.4 | Spine | |
| 6.2.4.1 | Minimally Invasive Fusion Surgeries | |
| 6.2.4.2 | Motion Preservation and Dynamic Stabilization | |
| 6.2.4.2.1 | Pedicle Based Rod Systems | |
| 6.2.4.2.2 | Interspinous Spacers | |
| 6.2.4.2.3 | Disc Arthoplasty/Replacement | |
| 6.2.5 | Fracture Fixation | |
| 6.2.5.1 | Bone Plates | |
| 6.2.5.2 | Screws | |
| 6.2.5.3 | Pins | |
| 6.2.5.4 | Rods | |
| 6.2.6 | Orthobiology | |
| 6.2.6.1 | Bone Grafts | |
| 6.3 | Ophthalmology | |
| 6.3.1 | Contact Lenses | |
| 6.3.2 | Intraocular Lenses | |
| 6.3.3 | Functional Replacement of Ocular Tissues | |
| 6.3.4 | Synthetic Corneas | |
| 6.3.5 | Others | |
| 6.4 | Dental | |
| 6.4.1 | Dental Bone Grafts and Substitutes | |
| 6.4.2 | Dental Membranes | |
| 6.5 | Wound Healing | |
| 6.5.1 | Wound Closure Devices | |
| 6.5.2 | Sutures | |
| 6.5.3 | Staples | |
| 6.5.4 | Surgical Haemostats | |
| 6.5.5 | Internatal Tissue Sealants | |
| 6.5.6 | Adhesion Barriers | |
| 6.5.7 | Hernia Meshes | |
| 6.6 | Plastic Surgery | |
| 6.6.1 | Soft-Tissue Fillers | |
| 6.6.2 | Craniofacial Surgery | |
| 6.7 | Neurological/Central Nervous System | |
| 6.7.1 | Shunting Systems | |
| 6.7.2 | Cortical Neural Prosthetics (CNP) | |
| 6.7.3 | Hydrogel Scaffolds for CNS Report | |
| 6.7.4 | Neural Stem Cell Encapsulation | |
| 6.8 | Tissue Engineering | |
| 6.8.1 | Scaffolds for Regenerative Medicine | |
| 6.8.2 | Nanomaterial for Biosensing | |
| 6.8.3 | Tailoring of Inorganic Nanoparticles | |
| 6.9 | Others | |
| 6.9.1 | Drug Delivery Systems | |
| 6.9.2 | Gastrointestinal Applications | |
| 6.9.3 | Bariatric Surgery | |
| 6.9.4 | Urinary Applications | |
| 7 | Global Biomaterials Market, by Region | |
| 7.1 | North America | |
| 7.1.1 | Biomaterials Market, by Type | |
| 7.1.2 | Biomaterials Market, by Application | |
| 7.1.3 | Biomaterials Market, by Country | |
| 7.1.3.1 | The U.S. | |
| 7.1.3.1.1 | Biomaterials-Based Research in the U.S | |
| 7.1.3.1.2 | Growing Demand for Plastic Surgeries in the U.S. | |
| 7.1.3.1.3 | Conferences and Symposiums on Biomaterials in the U.S. | |
| 7.1.3.1.4 | Increase in Cancer Incidence | |
| 7.1.3.1.5 | Growing Prevalence of Cardiovascular Diseases | |
| 7.1.3.1.6 | Regulations in the U.S. | |
| 7.1.3.2 | Canada | |
| 7.1.3.2.1 | Growth in the Aging Population | |
| 7.1.3.2.2 | Growing Development Activities for Biomaterials in Canada | |
| 7.1.3.3 | Mexico | |
| 7.1.3.3.1 | Growing R&D activity for Biomaterials in Mexico | |
| 7.1.3.3.2 | Emergence of Dental Growth | |
| 7.2 | Europe | |
| 7.2.1 | Biomaterials Market, by Type | |
| 7.2.2 | Biomaterials Market, by Application | |
| 7.2.3 | Biomaterials Market, by Country | |
| 7.2.3.1 | Germany | |
| 7.2.3.2 | The U.K. | |
| 7.2.3.3 | France | |
| 7.2.3.4 | Spain | |
| 7.2.3.5 | Italy | |
| 7.2.3.6 | Russia | |
| 7.2.3.7 | Rest of Europe(RoE) | |
| 7.3 | Asia Pacific | |
| 7.3.1 | Biomaterials Market, by Type | |
| 7.3.2 | Biomaterials Market, by Application | |
| 7.3.3 | Biomaterials Market, by Country | |
| 7.3.3.1 | China | |
| 7.3.3.2 | Japan | |
| 7.3.3.3 | India | |
| 7.3.3.4 | South Korea | |
| 7.3.3.5 | Rest of Asia Pacific | |
| 7.4 | Middle East & Africa | |
| 7.4.1 | Biomaterials Market, by Type | |
| 7.5 | South America | |
| 7.5.1 | Biomaterials Market, by Type | |
| 8 | Company Profiles | |
| 8.1 | BASF SE | |
| 8.1.1 | Company Overview | |
| 8.1.2 | Financials | |
| 8.1.2.1 | Financial Summary | |
| 8.1.3 | BASF SE: SWOT Analysis | |
| 8.2 | Bioactive Bone Substitutes Ltd. | |
| 8.2.1 | Company Overview | |
| 8.2.2 | About the Company | |
| 8.3 | Berkeley Advanced Biomaterials Inc. | |
| 8.3.1 | Company Overview | |
| 8.3.2 | Product Portfolio | |
| 8.3.3 | About the Company | |
| 8.4 | Bioretec Ltd. | |
| 8.4.1 | Company Overview | |
| 8.4.2 | About the Company | |
| 8.5 | CAM Bioceramics B.V. | |
| 8.5.1 | Company Overview | |
| 8.5.2 | About the Company | |
| 8.6 | Carpenter Technology Corporation | |
| 8.6.1 | Company Overview | |
| 8.6.2 | Product Portfolio | |
| 8.6.3 | Overall Financials | |
| 8.6.3.1 | Financial Summary | |
| 8.6.4 | SWOT Analysis | |
| 8.7 | Celanese Corporation | |
| 8.7.1 | Company Overview | |
| 8.7.2 | Product Portfolio | |
| 8.7.3 | Financials | |
| 8.7.3.1 | Financial Summary | |
| 8.7.4 | SWOT Analysis | |
| 8.8 | Collagen Solutions | |
| 8.8.1 | Company Overview | |
| 8.8.2 | Product Portfolio | |
| 8.8.3 | Overall Financials | |
| 8.8.3.1 | Financial Summary | |
| 8.8.4 | SWOT Analysis | |
| 8.9 | Corbion N.V. | |
| 8.9.1 | Company Overview | |
| 8.9.2 | Overall Financials: | |
| 8.9.2.1 | Financial Summary | |
| 8.9.3 | SWOT Analysis | |
| 8.1 | Covestro AG | |
| 8.10.1 | Company Overview | |
| 8.10.2 | Product Portfolio | |
| 8.10.3 | Overall Financials: | |
| 8.10.3.1 | Financial Summary | |
| 8.10.4 | SWOT Analysis | |
| 8.11 | Koninklijke DSM N.V. | |
| 8.11.1 | Company Overview | |
| 8.11.2 | Product Portfolio | |
| 8.11.3 | Overall Financials: | |
| 8.11.3.1 | Financial Summary | |
| 8.11.4 | SWOT Analysis | |
| 8.12 | Evonik Industries | |
| 8.12.1 | Company Overview | |
| 8.12.2 | Product Portfolio | |
| 8.12.3 | Overall Financials: | |
| 8.12.3.1 | Financial Summary | |
| 8.12.4 | SWOT Analysis | |
| 8.13 | Invibio Biomaterial Solutions | |
| 8.13.1 | Company Overview | |
| 8.13.2 | About the Company | |
| 8.14 | Regentis Biomaterials | |
| 8.14.1 | Company Overview | |
| 8.14.2 | About the Company | |
| 8.15 | Zimmer Biomet Holdings Inc. | |
| 8.15.1 | Company Overview | |
| 8.15.2 | Product Portfolio | |
| 8.15.3 | Overall Financials: | |
| 8.15.3.1 | Financial Summary | |
| 8.15.4 | SWOT Analysis | |
| List of Tables | ||
| Table 1 | Global Biomaterials Market Snapshot, 2017 and 2021 | |
| Table 3.1 | Biomaterials Market Competitive Analysis, by Revenue, 2016 | |
| Table 3.2 | Agreements, Contracts, Collaborations, Joint Ventures & Partnerships | |
| Table 3.3 | Key Business Expansion Activities | |
| Table 3.4 | Key Product Launches | |
| Table 3.5 | Key Mergers & Acquisitions | |
| Table 3.6 | Other Developments | |
| Table 5.1 | Global Biomaterials Market, by Type, (2016 – 2021) | |
| Table 5.2 | Metal based Biomaterials used in the Biomedical Application | |
| Table 5.3 | Global Metal Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.4 | Synthetic and Natural Polymers Used in Biomedical Applications | |
| Table 5.5 | PEEK Based biomaterials | |
| Table 5.6 | Global Metal Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.7 | Properties of Polymers Needed for Specific Biomaterials Applications | |
| Table 5.8 | Overview of Ceramic based Biomaterials Market | |
| Table 5.9 | Global Ceramic Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.10 | Different Types of Ceramic Needed for Biomaterial Applications | |
| Table 5.11 | Collagen Biomaterials Market, by Region, 2016-2021 | |
| Table 5.12 | Global Inorganic Based Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.13 | Global Radiopaque Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.14 | Global Regenerative Biomaterials Market, by Region, (2016 – 2021) | |
| Table 5.15 | Global Hybrid Biomaterials Combinations Market, by Region, (2016 – 2021) | |
| Table 6.1 | Application Overview of Biomaterials, by Devices | |
| Table 6.2 | Global Biomaterials Market, by Application, (2016 – 2021) | |
| Table 6.3 | Biomaterials used in Cardiovascular system | |
| Table 6.4 | Cardiovascular Biomaterials Market, by Medical Devices, (2016 – 2021) | |
| Table 6.5 | Cardiovascular Biomaterials Market, by Region, (2016 – 2021) | |
| Table 6.6 | Factors Leading to the Cardiovascular Diseases in North America | |
| Table 6.7 | Biomaterials used in Orthopedic Applications | |
| Table 6.8 | Orthopedic Biomaterials Market, by Sub-Application, (2016 – 2021) | |
| Table 6.9 | Past vs. Present Materials used in Hip, Shoulder, and Knee Replacements | |
| Table 6.10 | Joint Replacement Orthopedic Biomaterials Materials Market, by Type, (2016 – 2021) | |
| Table 6.11 | FDA Approved Injectable HA Viscossupplementation Products | |
| Table 6.12 | Degradation Time of Biomaterials Used in Bioabsorbable Suture Anchors | |
| Table 6.13 | Degradation Time of Biomaterials used in Biresorbable Suture Anchors | |
| Table 6.14 | Orthopedic Biomaterials Market, by Region, (2016 – 2021) | |
| Table 6.15 | Ophthalmology Biomaterials Market, by Region, (2016 – 2021) | |
| Table 6.16 | Dental Biomaterials Market, by Region, (2016-2021) | |
| Table 6.17 | Wound Healing Biomaterials Market, by Region (2016-2021) | |
| Table 6.18 | Surgical Procedures Performed for Plastic Surgery, By Country, 2015 | |
| Table 6.19 | Non-Surgical Procedures Performed for Plastic Surgery, By Country, 2015 | |
| Table 6.20 | Plastic Surgery Biomaterials Market, by Region (2016-2021) | |
| Table 6.21 | Neurological/Central Nervous System Biomaterials Market, by Region (2016-2021) | |
| Table 6.22 | Tissue Engineering Biomaterials Market, by Region (2016-2021) | |
| Table 6.23 | Other Applications Biomaterials Market, by Region (2016-2021) | |
| Table 7.1 | Global Biomaterials Market, by Region, (2016 – 2021) | |
| Table 7.2 | North American Biomaterials Market, by Type, (2016 – 2021) | |
| Table 7.3 | North America Biomaterials Market, by Application, (2016 – 2021) | |
| Table 7.4 | North American Biomaterials Market by Country, (2016 – 2021) | |
| Table 7.5 | The U.S. Biomaterials Market, by Application, (2016–2021) | |
| Table 7.6 | Canadian Population on Basis of Age above 65, 1851 to 2041 | |
| Table 7.7 | Canadian Biomaterials Market, by Application, 2017-2021 | |
| Table 7.8 | Mexico Biomaterials Market, by Application, 2017-2021 | |
| Table 7.9 | European Biomaterials Market (2016-2021), by Type | |
| Table 7.10 | European Biomaterials Market, by Application, (2016-2021) | |
| Table 7.11 | European Biomaterials Market by Country, (2016 – 2021) | |
| Table 7.12 | German Biomaterials Market, by Application, (2016–2021) | |
| Table 7.13 | The U.K. Biomaterials Market, by Application, (2016–2021) | |
| Table 7.14 | France Biomaterials Market, by Application, (2016–2021) | |
| Table 7.15 | Spain Biomaterials Market, by Application, (2016–2021) | |
| Table 7.16 | Italy Biomaterials Market, by Application, (2016–2021) | |
| Table 7.17 | Russian Biomaterials Market, by Application, (2016–2021) | |
| Table 7.18 | Rest of Europe Biomaterials Market, by Application, (2016–2021) | |
| Table 7.19 | Asia-Pacific Biomaterials Market, by Type, (2016-2021) | |
| Table 7.20 | Asia-Pacific Biomaterials Market, by Application, (2016 – 2021) | |
| Table 7.21 | Asia-Pacific Biomaterials Market by Country, (2016 – 2021) | |
| Table 7.22 | China Biomaterials Market, by Application, (2016–2021) | |
| Table 7.23 | Japan Biomaterials Market, by Application, (2016–2021) | |
| Table 7.24 | India Biomaterials Market, by Application, (2016–2021) | |
| Table 7.25 | South Korean Biomaterials Market, by Application, 2016-2021 | |
| Table 7.26 | Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021 | |
| Table 7.27 | Middle East & Africa Biomaterials Market, by Type, (2016 – 2021) | |
| Table 7.28 | Middle East & Africa Biomaterials Market, by Application, (2016 – 2021) | |
| Table 7.29 | South American Biomaterials Market, by Type, (2016 – 2021) | |
| Table 7.30 | South American Biomaterials Market, by Application, (2016 – 2021) | |
| List of Figures | ||
| Figure 1 | Evolution of Biomaterials | |
| Figure 2 | Global Biomaterials Market Snapshot, 2016-2021 | |
| Figure 3 | Global Biomaterials Market Share and Size, by Type, 2017 and 2021 | |
| Figure 4 | Global Biomaterials Market Share, by Application: 2017 & 2021 | |
| Figure 5 | Global Biomaterials Market, by Region, 2017 and 2021 | |
| Figure 6 | Global Biomaterials Market, by Country, 2016 and 2021 | |
| Figure 1.1 | Global Biomaterials Market Scope | |
| Figure 1.2 | Report Design | |
| Figure 1.3 | Sources of Secondary Research | |
| Figure 1.4 | Data Triangulation | |
| Figure 1.5 | Top Down & Bottom Up Approach | |
| Figure 2.1 | Global Biomaterials Market Dynamics | |
| Figure 2.2 | Number of Plastic Surgery Procedures and Percentage Share, by Country, 2014 | |
| Figure 2.3 | Number of Plastic Surgery Procedures in the U.S., by Type, 2015 | |
| Figure 2.4 | Global Percentage of Aging Population | |
| Figure 2.5 | Global Percentage of Aging Population | |
| Figure 2.6 | Cardiovascular Disease Death Rates, By Country, 2014 | |
| Figure 2.7 | Key Facts about Joint Replacement (2014-2015) | |
| Figure 2.8 | Global Medical Implants, by Application | |
| Figure 2.9 | Medical Implants in the Human Body | |
| Figure 2.10 | Key Trends in the Biomaterials Market | |
| Figure 3.1 | Global Biomaterials Market Opportunity Matrix, by Region, 2016 | |
| Figure 3.2 | Global Biomaterials Market Opportunity Matrix, by Country, 2016 | |
| Figure 3.3 | Global Biomaterials Market Opportunity Matrix, by Country, 2021 | |
| Figure 3.4 | Country Share Analysis of Global Biomaterials Market, 2016 | |
| Figure 3.5 | R&D Focus Areas of Axio Bio | |
| Figure 3.6 | R&D Analysis of Key Market Players | |
| Figure 3.7 | Share of Key Market Strategies & Developments | |
| Figure 3.8 | Total Number of Strategies & Developments | |
| Figure 4.1 | Supply Chain Analysis of Biomaterials Market | |
| Figure 4.2 | Biomaterial Science and a Path from a Need to Manufactured Medical Device | |
| Figure 4.3 | Porter’s Five Forces Analysis of Biomaterials Market | |
| Figure 4.4 | Future Trends and Developments in the Biomaterials Market | |
| Figure 5.1 | Global Biomaterials Market Size, by Type, 2017 and 2021 | |
| Figure 5.2 | Global Biomaterials Market, by Type, 2016-2021 | |
| Figure 5.3 | Global Biomaterials Market Share, by Type, 2016-2021 | |
| Figure 5.4 | Different Types of Biomaterials in Different Applications | |
| Figure 5.5 | Global Metal based Biomaterials Market Size, (2016 – 2021) | |
| Figure 5.6 | Evolution of Gold based Biomaterials in Medical Applications | |
| Figure 5.7 | Application Overview of Gold | |
| Figure 5.8 | Application Overview of Nitinol Based Biomaterials | |
| Figure 5.9 | Alloy Composition of Nitinol | |
| Figure 5.10 | Global Metal Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.11 | Global Polymer Based Biomaterials Market, 2017-2021 | |
| Figure 5.12 | Polymer based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.13 | Global Ceramic Based Biomaterials Market, 2017-2021 | |
| Figure 5.14 | Ceramic Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.15 | Global Natural Biomaterials Market, 2017-2021 | |
| Figure 5.16 | Collagen Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.17 | Properties of Inorganic Glass | |
| Figure 5.18 | Inorganic Glass Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.19 | History of Calcium Phosphate Based Biomaterials | |
| Figure 5.20 | Inorganic Based Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.21 | Global Radiopaque Biomaterials Market, 2017-2021 | |
| Figure 5.22 | Radiopaque Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.23 | Regenerative Biomaterials Market, by Region, 2016-2021 | |
| Figure 5.24 | Global Hybrid Biomaterial Combinations Market, 2017-2021 | |
| Figure 5.25 | Hybrid Biomaterial Combinations Market, by Region, 2016-2021 | |
| Figure 6.1 | Global Biomaterials Market, by Application | |
| Figure 6.2 | Global Biomaterials Market, by Application, 2017 and 2021 | |
| Figure 6.3 | Medical Devices and their Blood Contact Time | |
| Figure 6.4 | Number of Procedures in Joint Construction, 2016 | |
| Figure 6.5 | Global Ophthalmology Biomaterials Market, 2017-2021 | |
| Figure 6.6 | Properties of Polymer Based Biomaterials in Ophthalmology | |
| Figure 6.7 | Percent Share of Contact Lenses, by Region, 2014 | |
| Figure 6.8 | Global Dental Biomaterials Market, (2016-2021) | |
| Figure 6.9 | Key Facts and Figures on Dental Implantation in America | |
| Figure 6.10 | Global Wound Healing Biomaterials Market, (2016 – 2021) | |
| Figure 6.11 | Global Plastic Surgery Biomaterials Market, (2016 – 2021) | |
| Figure 6.12 | Global Neurological/Central Nervous System Biomaterials Market, (2016 – 2021) | |
| Figure 6.13 | Formation Engineered Tissue | |
| Figure 6.14 | Global Tissue Engineering Biomaterials Market, (2016 – 2021) | |
| Figure 6.15 | Properties of Biomaterial Scaffolds | |
| Figure 6.16 | Global Other Applications Biomaterials Market, (2016 – 2021) | |
| Figure 7.1 | Biomaterials Market Growth Rate, by Region | |
| Figure 7.2 | Biomaterials Market Growth Rate, by Region, 2017 and 2021 | |
| Figure 7.3 | North American Biomaterials Market Snapshot, 2016-2021 | |
| Figure 7.4 | Factors Driving the Biomaterials Market in North American Biomaterials, 2017 and 2021 | |
| Figure 7.5 | North American Distribution of Orthopedic Surgery Procedures, 2015 | |
| Figure 7.6 | Surgical Procedures in North America, 2015 and 2016 | |
| Figure 7.7 | Non-Surgical Procedures in North America, 2015 and 2016 | |
| Figure 7.8 | The U.S. Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.9 | Increase in Plastic Surgeries in the U.S. from 2000 to 2015 | |
| Figure 7.10 | Cancer Cases and Death Estimation in the U.S., 2017 | |
| Figure 7.11 | Facts and Risks Associated with Cardiovascular Diseases in the U.S. | |
| Figure 7.12 | Canadian Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.13 | Facts and Risks associated with Cardiovascular Diseases in the Canada | |
| Figure 7.14 | Mexico Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.15 | Global European Biomaterials Market, 2017-2021 | |
| Figure 7.16 | Factors Driving the Biomaterials Market in European Biomaterials, 2017 and 2021 | |
| Figure 7.17 | Percent Share of different Kind of Diseases in Europe, by Male and Female, 2016 | |
| Figure 7.18 | German Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.19 | The U.K. Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.20 | Common Plastic Surgery Procedure in the U.K. | |
| Figure 7.21 | France Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.22 | Spain Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.23 | Italy Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.24 | Russia Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.25 | Rest of Europe Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.26 | Asia-Pacific Biomaterials Market Snapshot, 2016-2021 | |
| Figure 7.27 | Factors Driving the Biomaterials Market in Asia-Pacific, 2017 and 2021 | |
| Figure 7.28 | China Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.29 | Japan Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.30 | India Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.31 | Percentage of Heart Attack among Indians for Different Age Groups | |
| Figure 7.32 | South Korean Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.33 | Indonesian Medical Device Regulation System | |
| Figure 7.34 | Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021 | |
| Figure 7.35 | Middle East & Africa Biomaterials Market, 2017-2021 | |
| Figure 7.36 | South American Biomaterials Market, by Type, 2017-2021 | |
| Figure 8.1 | BASF SE: Overall Financials, 2014-2016 | |
| Figure 8.2 | BASF SE: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.3 | BASF SE: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.4 | Carpenter Technology Corporation: Overall Financials, 2014-2016 | |
| Figure 8.5 | Carpenter Technology Corporation: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.6 | Carpenter Technology Corporation: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.7 | Celanese Corporation: Overall Financials, 2014-2016 | |
| Figure 8.8 | Celanese Corporation: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.9 | Celanese Corporation: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.10 | Collagen Solutions: Overall Financials, 2014-2016 | |
| Figure 8.11 | Collagen Solutions: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.12 | Corbion N.V.: Overall Financials, 2014-2016 | |
| Figure 8.13 | Corbion N.V.: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.14 | Corbion N.V.: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.15 | Corbion N.V.: Biochemical Sub-Segment Revenue Mix, 2014-2016 | |
| Figure 8.16 | Covestro AG: Overall Financials, 2014-2016 | |
| Figure 8.17 | Covestro AG: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.18 | Covestro AG: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.19 | Koninklijke DSM N.V.: Overall Financials, 2014-2016 | |
| Figure 8.20 | Koninklijke DSM N.V.: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.21 | Koninklijke DSM N.V.: Business Segment Revenue Mix, 2013-2015 | |
| Figure 8.22 | Evonik Industries: Overall Financials, 2014-2016 | |
| Figure 8.23 | Evonik Industries: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.24 | Evonik Industries: Business Segment Revenue Mix, 2014-2016 | |
| Figure 8.25 | Zimmer Biomet Holdings Inc.: Overall Financials, 2014-2016 | |
| Figure 8.26 | Zimmer Biomet Holdings Inc.: Geographic Revenue Mix, 2014-2016 | |
| Figure 8.27 | Zimmer Biomet Holdings Inc.: Business Segment Revenue Mix, 2014-2016 | |
Biomaterial is referred to any substance which is engineered to become biocompatible for its interaction with the biological systems. Biomaterials can be categorized as synthetic and natural. The synthetic materials consist of metals, polymers and ceramics, whereas natural biomaterials derived from natural sources include animal tissues or are engineered in the laboratory. Some tissues are harvested from animal sources such as cows or pigs. The interaction of these biomaterials with the human body aids in the treatment, augmentation, repairing or replacement of a tissue in the body.
The biomaterials market is majorly segmented by type, application and geography. The major categories by type include metal based, polymer based, ceramic based, regenerative biomaterials, inorganic glass, radiopaque biomaterials, natural biomaterials and hybrid combinations biomaterials. The major applications include cardiovascular, orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), tissue engineering and others such as drug delivery, urinary applications among others. By geography, the global biomaterials is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa and Latin America. The global biomaterials market is expected to reach $151.65 billion by 2021, growing at a CAGR of 16.0% between 2017 and 2021.
The biomaterials market is driven by a number of factors such as superior properties of biomaterials, increasing funds as well as aids by government for research purposes, rise in wound healing therapies & plastic surgeries, growing geriatric population, rising prevalence of cardiovascular diseases, increasing awareness of regenerative medicine, high rate of orthopedic disorders, and growing demand for implantable devices. However, biocompatabilty issues, stringent safety regulations, and limitations of biomaterial based products are hampering the growth of the biomaterials market. Increasing obesity, introduction of biomaterials in cancer research, and rising patient awareness and improved lifestyle in growing economies such as India, China, and Brazil are expected to create opportunities in the biomaterials market.
Figure 1
Global Biomaterials Market Snapshot
Secondary research, Annual Reports, SEC Filings, Investor Presentations, Articles, Expert Insights, and BIS Research Analysis
The biomaterials market is segmented into various types, namely: metal based (such as stainless steel, cobalt-chrome alloys, titanium and titanium alloys, gold, silver, magnesium, and nitinol), polymer based (such as polypropylene, polyethylene terephthalate, polyetheretherketone, polytetrafluoroethylene, polyglycolide, silicone rubber, and PMMA, among others), ceramic based (such as calcium phosphate, zirconia, calcium sulphate, and carbon, among others), regenerative biomaterials, inorganic glass, radiopaque biomaterials, natural biomaterials (such as hyaluronic acid, collagen, gelatin, fibrin, cellulose, chitin, and silk, among others), and hybrid combinations biomaterials. Metal based biomaterials dominated the global biomaterials market with a share of approximately 24% in 2016. The market size of this segment is projected to reach $34.62 billion by 2021. Exceptionally high strength, biocompatibility and biodegradable properties allow these metals to be viably used for biomaterial applications.
The metallic biomaterials and their alloys are used majorly in load-bearing applications for which the desired properties are high strength, stiffness, corrosion resistance, fatigue strength, easy sterilization, shape memory and biocompatabilty, among others. For similar reasons, metals are the most widely used biomaterials for load-bearing implants and orthopedic surgeries involving metallic implants. Metals are used in all the applications of biomaterials such as cardiovascular, orthopedic, ophthalmology, and dental, among others. From simple wires, rods, pins, screws to fracture fixation plates and total joint prostheses (artificial joints) for hips, knees, shoulders, and ankles, among others, metals are used in all kinds of applications including maxillofacial surgery, cardiovascular surgery, dental materials etc.
On the basis of application, biomaterials market is segmented into cardiovascular, orthopedics, ophthalmology, wound healing, plastic surgery, tissue engineering, neurological/central nervous system, and others. The cardiovascular application segment dominated the biomaterials market with a market share of approximately 34% in 2016. The increasing use of biomaterials in cardiovascular applications is majorly subjected to its biocompatibility as biomaterials comes in contact blood, vascular endothelial cells, fibroblasts, and myocardium, as well as a number of other cells and a cellular matrix material.
Additionally, according to World Health Organization (WHO), in 2015, approximately 17.7 million population died from cardiovascular diseases, thereby, representing 31% of all the global deaths. The main risk factors of the cardiovascular diseases include tobacco use, diabetes, hyperlipidemia, unhealthy diet and obesity, physical inactivity, alcohol consumption, hypertension, and stroke, among others. Out of 17.7 million deaths, approximately 7.4 million people died due to coronary heart disease and 6.7 million from stroke.
On the basis of geography, North America dominated the biomaterials market. The increasing demand for surgeries such as cosmetic, and orthopedic (joint replacement) among others, in the healthcare industry is giving a much needed thrust to the biomaterials market in the North American region. Another major reason behind the growth of the biomaterials market in the North American region is that the countries such as the U.S., Canada, and Mexico have a strong support of the government in terms of grants, funds and subsidies in R&D activities. Some of the major players operating in the North American region include Royal DSM, Invibio Ltd., Carpenter Technology Corporation, CAM Bio ceramics BV, Collagen Solutions PLC, Berkeley Advanced Biomaterials, Corbion N.V., Zimmer Biomet Holdings, Inc., and Evonik Industries AG.
Some of the key players in the biomaterials market are BASF, BBS, Berkley Advanced Biomaterial Inc., Bioretec Ltd., CAM Bioceramics, Carpenter Technology Corporation, Celanese Corp., Collagen Solutions, Corbion, Covestro, Royal DSM, Evonik Industries, Invibio, Straumann, and Zimmer Biomet. These companies provide a broad product portfolio for specific needs and industrial applications. These companies are actively aiming at an increased number of agreements, partnerships, collaborations, & contracts and products to expand their operations, thereby, enhancing their share in the biomaterials market.
We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.
With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.
Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.
